Feature | EP Lab | August 09, 2021

Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

The latest science in EP to treat cardiac arrhythmias

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them from the Heart Rhythm Society (HRS) 2021 meeting. For more information on the meeting, visit https://heartrhythm.com.

Late Breaking Clinical Trials and Registry
Thursday, July 29, 8:15 AM - 9:15 AM CDT

   • STROKE VT Trial: Safety And Efficacy Of Periprocedural Direct Oral Anticoagulant Versus Aspirin Use For Reduction Of The Risk Of Cerebrovascular Events In Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation. Presented by Dhanunjaya R. Lakkireddy.

   • A Randomized Pilot Study Of Perioperative Spinal Cord Stimulation To Prevent Post-CABG Atrial Fibrillation: 30-day Safety And Efficacy Outcomes. Presented by Alexander B. Romanov.

   • Clinical Outcomes Of Left Bundle Branch Area Pacing Compared To Right Ventricular Pacing: Results From The Geisinger-Rush Conduction System Pacing. Presented by Parikshit S. Sharma.

   • A Randomized Trial Of Early First-Line Catheter Ablation For Ventricular Tachycardia: Results From The Pan-Asia United States Prevention Of Sudden Cardiac Death Trial (PAUSE-SCD). Presented by Roderick Tung.

Late Breaking Clinical Innovations
Thursday, July 29, 12:45 PM - 1:45 PM CDT

   • Continuous ECG Monitoring Versus Mobile Telemetry: A Comparison Of Arrhythmia Diagnostics Between Human And Algorithm Dependent Systems. Presented by Mark Willcox, M.D.

   • Leadless LV Stimulation With Wise-CRT System - Initial Experience In New U.S. Centers: Results From Phase I Of Solve-CRT Study (non-randomized, Roll-in Phase).Presented by Jagmeet P Singh.

   • Ultralow Temperature Cryoablation For Atrial Fibrillation, Primary Outcome Results On Efficacy And Safety. The Cryocure-2 Study. Presented by Tom De Potter.

   • Analysis Of Behavior Of Af Sources With Electrographic Flow Mapping. Presented by David E. Haines.

Late Breaking Clinical Trials Updates
Friday, July 30, 9:30 AM - 10:30 AM CDT

   • Oral Contraceptive Use And The Risk Of Cardiac Events In Women With Congenital Long QT Syndrome. Presented by Ilan Goldenberg.

   • Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (EAST – AFNET 4). Presented by Andreas Rillig.

   • Economic Outcomes Of Ablation Versus Drug Therapy In CABANA. Presented by Derek Chew.

   • Safety And Effectiveness Of Multi-site Pacing In Initial Non-responders To Conventional Cardiac Resynchronization Therapy. Presented by Samir F. Saba.

 

Late Breaking Science
Friday, July 30, 12:45 PM - 1:45 PM CDT

   • Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes In Patients With Inappropriate Sinus Tachycardia (Susruta-IST Registry). Presented by Dhanunjaya R. Lakkireddy.

   • Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT): Results From International LBBAP Collaborative Study Group. Presented by Marek Jastrzebski.

   • Ganglionated Plexus Ablation To Prevent Atrial Fibrillation (GANGLIA-AF Trial). Presented by Min-young Kim.

   • First-in-human Clinical Experience With A Novel 4-D ICE Catheter During Catheter Ablation And LAA Closure Procedures. Presented by Vivek Y. Reddy.

 

Related HRS Conference Coverage:

VIDEO: Multi-Site Pacing Effective in Initial Nonresponders to Conventional Cardiac Resynchronization Therapy — Interview with Samir Saba, M.D.

Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

 

VIDEO: EP Trends and New Technology From Biosense Webster at HRS 2021

Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy

Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021

New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation

Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award

 

 

Related Content

Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future.

Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future. Getty Images

News | Cardiovascular Clinical Studies | June 24, 2021
June 24, 2021 — Data captured in American College of Cardiology (ACC)...
Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.

Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium. 

News | Cardiovascular Clinical Studies | January 27, 2021
January 27, 2021 — A New York Institute of Technology research te
Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...